Image Analysis

Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer. The aim is to pre-screen patients for the MSI-H biomarker, which is found...

Concord, MA (12/14/2023) – Corista, a leader in digital pathology solutions, announced its DP3 platform has been certified with the CE In Vitro Diagnostic (IVDR) marking, for routine diagnosis in the European Union and United Kingdom. The CE...

ArteraAI, CorePlus collaboration aims to further validate the ArteraAI Prostate Test in the Hispanic population SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and...

Indica Labs has announced a webinar for February 2024 teaching attendees about applications of the ACD RNAscope™ HiPlex assay. Hedgehog Signaling pathway in Thymic Differentiation - An in situ Single Cell Resolution Investigation Date:...

Lumea: Enabling pathologists to use cutting-edge diagnostic solutions for decision support in Gleason grading prostate cancer specimens. LEHI, UTAH, USA, December 7, 2023 /EINPresswire.com/ -- Lumea Inc., a leader in integrated digital...

Boston, MA – [12/7/2023] – Corista, a leader in digital pathology solutions, today announces a strategic partnership with AGFA HealthCare, a renowned name in diagnostic imaging and healthcare IT solutions. This alliance represents an...